.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Chubb
AstraZeneca
QuintilesIMS
Deloitte
Citi
Moodys
Boehringer Ingelheim
Covington
Federal Trade Commission

Generated: December 17, 2017

DrugPatentWatch Database Preview

DOXAZOSIN MESYLATE Drug Profile

« Back to Dashboard

When do Doxazosin Mesylate patents expire, and when can generic versions of Doxazosin Mesylate launch?

Doxazosin Mesylate is a drug marketed by Accord Hlthcare, Actavis Elizabeth, Apotex, Dava Pharms Inc, Genpharm, Idt Australia Ltd, Ivax Sub Teva Pharms, Mylan, Nesher Pharms, Pliva, Sandoz, Teva, Watson Labs Inc, and Zydus Pharms Usa Inc. and is included in fifteen NDAs.

The generic ingredient in DOXAZOSIN MESYLATE is doxazosin mesylate. There are thirteen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the doxazosin mesylate profile page.
Drug patent expirations by year for DOXAZOSIN MESYLATE

Pharmacology for DOXAZOSIN MESYLATE

Medical Subject Heading (MeSH) Categories for DOXAZOSIN MESYLATE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
SandozDOXAZOSIN MESYLATEdoxazosin mesylateTABLET;ORAL075646-001Oct 18, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
MylanDOXAZOSIN MESYLATEdoxazosin mesylateTABLET;ORAL075509-004Oct 19, 2000ABRXNoNo► Subscribe► Subscribe► Subscribe
TevaDOXAZOSIN MESYLATEdoxazosin mesylateTABLET;ORAL075353-003Jan 12, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa IncDOXAZOSIN MESYLATEdoxazosin mesylateTABLET;ORAL208719-004Jul 7, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
TevaDOXAZOSIN MESYLATEdoxazosin mesylateTABLET;ORAL075353-001Jan 12, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
TevaDOXAZOSIN MESYLATEdoxazosin mesylateTABLET;ORAL075536-003Oct 18, 2000ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs IncDOXAZOSIN MESYLATEdoxazosin mesylateTABLET;ORAL075426-003Oct 18, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva PharmsDOXAZOSIN MESYLATEdoxazosin mesylateTABLET;ORAL075453-004Oct 18, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Nesher PharmsDOXAZOSIN MESYLATEdoxazosin mesylateTABLET;ORAL075609-001Oct 18, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
MylanDOXAZOSIN MESYLATEdoxazosin mesylateTABLET;ORAL075509-001Oct 19, 2000ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Farmers Insurance
Deloitte
Cantor Fitzgerald
Federal Trade Commission
Citi
Argus Health
AstraZeneca
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot